GENZYME CORPORATION

Organization

FRAMINGTON, MA, US

BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Address
500 KENDALL STREET CAMBRIDGE MA 02142 6172527500
Mailing Address
500 KENDALL STREET CAMBRIDGE MA 02142
State Location
MA
State of Incorporation
MA

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Modified-IgG antibodies that bind transforming growth factor-β1 wit...
- Patent number 12,162,933
- Issue date Dec 10, 2024
- Genzyme Corporation
- Huawei Qiu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Systems and devices for producing biological products and methods o...
- Patent number 12,157,873
- Issue date Dec 3, 2024
- Genzyme Corporation
- Kevin Brower
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Grant
Biomarker of polycystic kidney disease and uses thereof
- Patent number 12,150,938
- Issue date Nov 26, 2024
- Genzyme Corporation
- Nikolai Bukanov
- G01 - MEASURING TESTING
Information Patent Grant
Methods for detecting AAV
- Patent number 12,123,880
- Issue date Oct 22, 2024
- Genzyme Corporation
- Xiaoying Jin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Site-specific antibody-drug conjugation through glycoengineering
- Patent number 12,110,338
- Issue date Oct 8, 2024
- Genzyme Corporation
- Clark Pan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Integrated continuous manufacturing of therapeutic protein drug sub...
- Patent number 12,110,312
- Issue date Oct 8, 2024
- Genzyme Corporation
- Konstantin Konstantinov
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Grant
Perfusion bioreactor with filtration systems
- Patent number 12,110,483
- Issue date Oct 8, 2024
- Genzyme Corporation
- Jiuyi Lu
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Grant
Bone-targeting antibodies
- Patent number 12,098,194
- Issue date Sep 24, 2024
- Genzyme Corporation
- Huawei Qiu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for treating neurological symptoms associated with lysosoma...
- Patent number 12,083,115
- Issue date Sep 10, 2024
- Genzyme Corporation
- Nigel Patrick Somerville Crawford
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Analytical ultracentrifugation for characterization of recombinant...
- Patent number 12,085,494
- Issue date Sep 10, 2024
- Genzyme Corporation
- Catherine R. O'Riordan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Multivariate spectral analysis and monitoring for biomanufacturing
- Patent number 12,073,924
- Issue date Aug 27, 2024
- Genzyme Corporation
- Dhanuka Pulasthi Wasalathanthri
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Grant
Glucosylceramide synthase inhibitors
- Patent number 12,060,349
- Issue date Aug 13, 2024
- Genzyme Corporation
- Elyse Bourque
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline form of Tolebrutinib
- Patent number 12,049,463
- Issue date Jul 30, 2024
- Genzyme Corporation
- Minhua Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of T-cell activation
- Patent number 12,043,665
- Issue date Jul 23, 2024
- Genzyme Corporation
- Yunxiang Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Analytical ultracentrifugation for characterization of recombinant...
- Patent number 12,031,894
- Issue date Jul 9, 2024
- Genzyme Corporation
- Catherine R. O'Riordan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Analytical ultracentrifugation for characterization of recombinant...
- Patent number 12,013,326
- Issue date Jun 18, 2024
- Genzyme Corporation
- Catherine R. O'Riordan
- G01 - MEASURING TESTING
Information Patent Grant
Perfusion culturing methods and uses thereof
- Patent number 12,006,510
- Issue date Jun 11, 2024
- Genzyme Corporation
- Agata Villiger-Oberbek
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of treating acid sphingomyelinase deficiency
- Patent number 11,998,592
- Issue date Jun 4, 2024
- Genzyme Corporation
- Wei-Lien Chuang
- G01 - MEASURING TESTING
Information Patent Grant
Humanized anti-complement factor Bb antibodies and uses thereof
- Patent number 11,999,780
- Issue date Jun 4, 2024
- Genzyme Corporation
- Graham Parry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Gene therapy for neurodegenerative disorders
- Patent number 11,975,043
- Issue date May 7, 2024
- Genzyme Corporation
- Marco A. Passini
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Therapeutic tyrosine kinase inhibitors for relapsing multiple scler...
- Patent number 11,969,418
- Issue date Apr 30, 2024
- Genzyme Corporation
- Meehyung Cho
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Gene therapy for neurometabolic disorders
- Patent number 11,957,765
- Issue date Apr 16, 2024
- Genzyme Corporation
- Marco A. Passini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-human CD52 immunoglobulins
- Patent number 11,945,874
- Issue date Apr 2, 2024
- Genzyme Corporation
- Bruce L Roberts
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Assays for detecting the presence or amount of an anti-drug antibody
- Patent number 11,927,596
- Issue date Mar 12, 2024
- Genzyme Corporation
- Ryan Grabert
- G01 - MEASURING TESTING
Information Patent Grant
Integrated continuous isolation of fluid streams from sterile proce...
- Patent number 11,920,120
- Issue date Mar 5, 2024
- Genzyme Corporation
- Robert Snow
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Continuous production of recombinant proteins
- Patent number 11,912,741
- Issue date Feb 27, 2024
- Genzyme Corporation
- Michael Coolbaugh
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapy for neurodegenerative disorders
- Patent number 11,911,440
- Issue date Feb 27, 2024
- Genzyme Corporation
- Marco A. Passini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sterile chromatography and manufacturing processes
- Patent number 11,912,739
- Issue date Feb 27, 2024
- Genzyme Corporation
- Rahul Godawat
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant AAV vectors expressing osteoprotective genes, including...
- Patent number 11,905,531
- Issue date Feb 20, 2024
- Genzyme Corporation
- Monica Dias Figueiredo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of abnormal bone conditions in acid sphingomyelinase defi...
- Patent number 11,898,175
- Issue date Feb 13, 2024
- Genzyme Corporation
- Ana Cristina Scheidt-Puga
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
Integrated Continuous Manufacturing of Therapeutic Protein Drug Sub...
- Publication number 20240417427
- Publication date Dec 19, 2024
- Genzyme Corporation
- Konstantin Konstantinov
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Application
Treatment of Dry Age-Related Macular Degeneration
- Publication number 20240401082
- Publication date Dec 5, 2024
- Genzyme Corporation
- Matthew Adamowicz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MARKER FOR ACID SPHINGOMYELINASE DISORDERS AND USES THEREOF
- Publication number 20240398907
- Publication date Dec 5, 2024
- Genzyme Corporation
- Wei-Lien CHUANG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF MULTIPLE SCLEROSIS WITH ANTI-CD40L ANTIBODIES
- Publication number 20240392022
- Publication date Nov 28, 2024
- Genzyme Corporation
- Christine FARENC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANALYTICAL ULTRACENTRIFUGATION FOR CHARACTERIZATION OF RECOMBINANT...
- Publication number 20240393222
- Publication date Nov 28, 2024
- Genzyme Corporation
- Catherine R. O'RIORDAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Methods of Controlling the Formation of Disulfide Bonds in Protein...
- Publication number 20240392030
- Publication date Nov 28, 2024
- Genzyme Corporation
- Kevin P. Brower
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF
- Publication number 20240391986
- Publication date Nov 28, 2024
- Genzyme Corporation
- Graham Parry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED GENE THERAPY FOR DM-1 MYOTONIC DYSTROPHY
- Publication number 20240384271
- Publication date Nov 21, 2024
- Genzyme Corporation
- Seng Cheng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF IMPROVING RAAV PRODUCTION
- Publication number 20240360423
- Publication date Oct 31, 2024
- Genzyme Corporation
- Srinivas Nellimarla
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Gene Therapy For Neurodegenerative Disorders
- Publication number 20240350584
- Publication date Oct 24, 2024
- Genzyme Corporation
- Marco A. PASSINI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SCFV-FC DIMERS THAT BIND TRANSFORMING GROWTH FACTOR-BETA1 WITH HIGH...
- Publication number 20240343790
- Publication date Oct 17, 2024
- Genzyme Corporation
- Huawei Qiu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DRUG FORMULATIONS OF 4-(3,3-DIFLUORO-2,2-DIMETHYL-PROPANOYL) -3,5-D...
- Publication number 20240299412
- Publication date Sep 12, 2024
- Genzyme Corporation
- Jerome Arigon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Perfusion Culturing Methods and Uses Thereof
- Publication number 20240287451
- Publication date Aug 29, 2024
- Genzyme Corporation
- Agata Villiger-Oberbek
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ASSAYS FOR DETECTING THE PRESENCE OR AMOUNT OF AN ANTI-DRUG ANTIBODY
- Publication number 20240288454
- Publication date Aug 29, 2024
- Genzyme Corporation
- Ryan Grabert
- G01 - MEASURING TESTING
Information Patent Application
INDOLE COMPOUNDS AND METHODS OF USE
- Publication number 20240279220
- Publication date Aug 22, 2024
- Genzyme Corporation
- Junkai Liao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-PD-1×4-1BB BINDING PROTEINS
- Publication number 20240262923
- Publication date Aug 8, 2024
- Genzyme Corporation
- Marta AMARAL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL PREDICTIVE BIOMARKERS FOR SECONDARY AUTOIMMUNITY AFTER LYMPHO...
- Publication number 20240254556
- Publication date Aug 1, 2024
- Genzyme Corporation
- Darren Phillip BAKER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT AAV VECTORS EXPRESSING OSTEOPROTECTIVE GENES, INCLUDING...
- Publication number 20240254454
- Publication date Aug 1, 2024
- Genzyme Corporation
- Monica DIAS FIGUEIREDO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DRUG FORMULATIONS OF (R)-1-(1-ACRYLOYLPIPERIDIN-3-YL)-4-AMINO-3-(4-...
- Publication number 20240238267
- Publication date Jul 18, 2024
- Genzyme Corporation
- Marilyn Calderone
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INDOLE COMPOUNDS AND METHODS OF USE
- Publication number 20240239784
- Publication date Jul 18, 2024
- Genzyme Corporation
- Junkai Liao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF
- Publication number 20240228599
- Publication date Jul 11, 2024
- Genzyme Corporation
- Sandip Panicker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS
- Publication number 20240217991
- Publication date Jul 4, 2024
- Genzyme Corporation
- John L. Kane
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODIFIED BINDING POLYPEPTIDES FOR OPTIMIZED DRUG CONJUGATION
- Publication number 20240218051
- Publication date Jul 4, 2024
- Genzyme Corporation
- Qun Zhou
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF ABNORMAL BONE CONDITIONS IN ACID SPHINGOMYELINASE DEFI...
- Publication number 20240218338
- Publication date Jul 4, 2024
- Genzyme Corporation
- Ana Cristina SCHEIDT-PUGA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE EDITING OF DEEP INTRONIC MUTATIONS
- Publication number 20240197837
- Publication date Jun 20, 2024
- Genzyme Corporation
- Guoxiang RUAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TROPOMYOSIN-RELATED KINASE (trk) INHIBITORS
- Publication number 20240189322
- Publication date Jun 13, 2024
- Genzyme Corporation
- John L. KANE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL FORMULATIONS OF TROPOMYOSIN RELATED KINASE (TRK) INH...
- Publication number 20240189223
- Publication date Jun 13, 2024
- Genzyme Corporation
- Harvey LIEBERMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VARIANT RNAi
- Publication number 20240182896
- Publication date Jun 6, 2024
- Genzyme Corporation
- Lisa M. STANEK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HYPERGLYCOSYLATED BINDING POLYPEPTIDES
- Publication number 20240182595
- Publication date Jun 6, 2024
- Genzyme Corporation
- Clark PAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESS FOR PREPARING SHP2 INHIBITORS
- Publication number 20240182485
- Publication date Jun 6, 2024
- Genzyme Corporation
- Mickaël ARNOLD
- C07 - ORGANIC CHEMISTRY

Trademarklast 30 trademarks

Information Trademark
98780016 - HEMASSIST SANOFI PATIENT SUPPORT
- Serial number 98780016
- Filing date Oct 1, 2024
- Genzyme Corporation
- 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
Information Trademark
98780052 - HEMASSIST
- Serial number 98780052
- Filing date Oct 1, 2024
- Genzyme Corporation
- 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
Information Trademark
98719318 - ZELRAYMI
- Serial number 98719318
- Filing date Aug 27, 2024
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98719344 - ZEQLUMO
- Serial number 98719344
- Filing date Aug 27, 2024
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98719338 - LYSVENURE
- Serial number 98719338
- Filing date Aug 27, 2024
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98719330 - VANRAYMI
- Serial number 98719330
- Filing date Aug 27, 2024
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98363007 - INFILBRAY
- Serial number 98363007
- Filing date Jan 18, 2024
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98286004 - ORYPKY
- Serial number 98286004
- Filing date Nov 27, 2023
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98243401 - HARKIPLY
- Serial number 98243401
- Filing date Oct 27, 2023
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98210611 - MYOZYME
- Serial number 98210611
- Filing date Oct 5, 2023
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98146318 - ZURYPKI
- Serial number 98146318
- Filing date Aug 23, 2023
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98146315 - RYDALODI
- Serial number 98146315
- Filing date Aug 23, 2023
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98144127 - FYDITRU
- Serial number 98144127
- Filing date Aug 22, 2023
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98144160 - SORYPKI
- Serial number 98144160
- Filing date Aug 22, 2023
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98054571 - QFITLIA
- Serial number 98054571
- Filing date Jun 22, 2023
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98042551 - QENLUVON
- Serial number 98042551
- Filing date Jun 14, 2023
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98042634 - KINLUVYAN
- Serial number 98042634
- Filing date Jun 14, 2023
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98042614 - ADONDITRU
- Serial number 98042614
- Filing date Jun 14, 2023
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98008648 - CARE CONNECT PERSONALIZED SUPPORT SERVICES
- Serial number 98008648
- Filing date May 23, 2023
- Genzyme Corporation
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
98002479 - KYNJUXO
- Serial number 98002479
- Filing date May 18, 2023
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98002517 - KYNLUVON
- Serial number 98002517
- Filing date May 18, 2023
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98002535 - ZUNRYPKI
- Serial number 98002535
- Filing date May 18, 2023
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98002440 - ZABUVLY
- Serial number 98002440
- Filing date May 18, 2023
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98002471 - QEVLUCA
- Serial number 98002471
- Filing date May 18, 2023
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98002461 - ZYCENVU
- Serial number 98002461
- Filing date May 18, 2023
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98002552 - EMRYPKEN
- Serial number 98002552
- Filing date May 18, 2023
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97925213 - ENPHILBRAY
- Serial number 97925213
- Filing date May 8, 2023
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97925401 - ITFILBRAY
- Serial number 97925401
- Filing date May 8, 2023
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97925372 - IRFILBRAY
- Serial number 97925372
- Filing date May 8, 2023
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97910293 - LONCENVU
- Serial number 97910293
- Filing date Apr 27, 2023
- Genzyme Corporation
- 5 - Pharmaceutical and veterinary preparations

GENZYME CORPORATION

Organization

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Modified-IgG antibodies that bind transforming growth factor-β1 wit...

Systems and devices for producing biological products and methods o...

Biomarker of polycystic kidney disease and uses thereof

Methods for detecting AAV

Site-specific antibody-drug conjugation through glycoengineering

Integrated continuous manufacturing of therapeutic protein drug sub...

Perfusion bioreactor with filtration systems

Bone-targeting antibodies

Methods for treating neurological symptoms associated with lysosoma...

Analytical ultracentrifugation for characterization of recombinant...

Multivariate spectral analysis and monitoring for biomanufacturing

Glucosylceramide synthase inhibitors

Crystalline form of Tolebrutinib

Inhibitors of T-cell activation

Analytical ultracentrifugation for characterization of recombinant...

Analytical ultracentrifugation for characterization of recombinant...

Perfusion culturing methods and uses thereof

Methods of treating acid sphingomyelinase deficiency

Humanized anti-complement factor Bb antibodies and uses thereof

Gene therapy for neurodegenerative disorders

Therapeutic tyrosine kinase inhibitors for relapsing multiple scler...

Gene therapy for neurometabolic disorders

Anti-human CD52 immunoglobulins

Assays for detecting the presence or amount of an anti-drug antibody

Integrated continuous isolation of fluid streams from sterile proce...

Continuous production of recombinant proteins

Gene therapy for neurodegenerative disorders

Sterile chromatography and manufacturing processes

Recombinant AAV vectors expressing osteoprotective genes, including...

Treatment of abnormal bone conditions in acid sphingomyelinase defi...

Patents Applicationslast 30 patents

Integrated Continuous Manufacturing of Therapeutic Protein Drug Sub...

Treatment of Dry Age-Related Macular Degeneration

MARKER FOR ACID SPHINGOMYELINASE DISORDERS AND USES THEREOF

TREATMENT OF MULTIPLE SCLEROSIS WITH ANTI-CD40L ANTIBODIES

ANALYTICAL ULTRACENTRIFUGATION FOR CHARACTERIZATION OF RECOMBINANT...

Methods of Controlling the Formation of Disulfide Bonds in Protein...

HUMANIZED ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF

TARGETED GENE THERAPY FOR DM-1 MYOTONIC DYSTROPHY

METHODS OF IMPROVING RAAV PRODUCTION

Gene Therapy For Neurodegenerative Disorders

SCFV-FC DIMERS THAT BIND TRANSFORMING GROWTH FACTOR-BETA1 WITH HIGH...

DRUG FORMULATIONS OF 4-(3,3-DIFLUORO-2,2-DIMETHYL-PROPANOYL) -3,5-D...

Perfusion Culturing Methods and Uses Thereof

ASSAYS FOR DETECTING THE PRESENCE OR AMOUNT OF AN ANTI-DRUG ANTIBODY

INDOLE COMPOUNDS AND METHODS OF USE

ANTI-PD-1×4-1BB BINDING PROTEINS

NOVEL PREDICTIVE BIOMARKERS FOR SECONDARY AUTOIMMUNITY AFTER LYMPHO...

RECOMBINANT AAV VECTORS EXPRESSING OSTEOPROTECTIVE GENES, INCLUDING...

DRUG FORMULATIONS OF (R)-1-(1-ACRYLOYLPIPERIDIN-3-YL)-4-AMINO-3-(4-...

INDOLE COMPOUNDS AND METHODS OF USE

ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF

COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS

MODIFIED BINDING POLYPEPTIDES FOR OPTIMIZED DRUG CONJUGATION

TREATMENT OF ABNORMAL BONE CONDITIONS IN ACID SPHINGOMYELINASE DEFI...

GENE EDITING OF DEEP INTRONIC MUTATIONS

TROPOMYOSIN-RELATED KINASE (trk) INHIBITORS

PHARMACEUTICAL FORMULATIONS OF TROPOMYOSIN RELATED KINASE (TRK) INH...

VARIANT RNAi

HYPERGLYCOSYLATED BINDING POLYPEPTIDES

PROCESS FOR PREPARING SHP2 INHIBITORS

Trademarklast 30 trademarks

98780016 - HEMASSIST SANOFI PATIENT SUPPORT

98780052 - HEMASSIST

98719318 - ZELRAYMI

98719344 - ZEQLUMO

98719338 - LYSVENURE

98719330 - VANRAYMI

98363007 - INFILBRAY

98286004 - ORYPKY

98243401 - HARKIPLY

98210611 - MYOZYME

98146318 - ZURYPKI